Deal News

AstraZeneca completes Gracell Biotechnologies acquisition for $1.2bn

AstraZeneca has concluded its acquisition of China-based clinical-stage biopharmaceutical company Gracell Biotechnologies for $1.2bn. The acquisition, initially agreed in December…

AstraZeneca completes Icosavax acquisition for $1.1bn

AstraZeneca has concluded the acquisition of the US-based clinical-stage biopharmaceutical company Icosavax in a $1.1bn deal. The latest development comes…

GSK concludes Aiolos Bio acquisition for $1.4bn

GSK has successfully concluded the acquisition of Aiolos Bio in a deal that could reach $1.4bn, marking a significant expansion…

AbbVie concludes acquisition of ImmunoGen for $10.1bn

AbbVie has completed the acquisition of ImmunoGen for $10.1bn, a move that significantly bolsters its oncology pipeline with promising treatments…

Telix to acquire QSAM Biosciences for $123.1m

Australia-based global biopharmaceutical company Telix Pharmaceuticals has agreed to acquire US-based QSAM Biosciences for $123.1m. The deal comes after the…

Kyowa Kirin acquires Orchard Therapeutics for $477.6m

Kyowa Kirin, a Japan-based global speciality pharmaceutical company, has announced the successful completion of its acquisition of Orchard Therapeutics, a…

Bristol Myers Squibb concludes Mirati acquisition for $5.8bn

BMS has concluded the acquisition of Mirati Therapeutics for $5.8bn, a move that significantly bolsters and diversifies its oncology portfolio.…

Sanofi signs agreement to acquire Inhibrx for $1.7bn

Sanofi has signed an agreement for the acquisition of all outstanding shares of publicly traded clinical-stage biopharmaceutical company Inhibrx for…

Sandoz to acquire Coherus’ CIMERLI ophthalmology franchise

Sandoz has entered an agreement for the acquisition of the CIMERLI ophthalmology franchise from Coherus BioSciences. This move is aimed…

Sun Pharma to acquire Taro shares for $347.73m

Sun Pharmaceutical has signed a definitive merger agreement for the acquisition of all outstanding ordinary shares of Taro Pharmaceutical not…

close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Vist our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close